Tedalinab

Overview

Tedalinab (GRC-10693) is a potent, orally active, and selective cannabinoid receptor 2 ( CB2 ) agonist. Tedalinab has >4700-fold functional selectivity for CB2 over CB1 . Tedalinab has potential for neuropathic pain and osteoarthritis treatment.

Application

Products | Products > Disease Areas > Urogenital Cancer | Products > Disease Areas > Pain | Products > Disease Areas > Cancer | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Disease Areas > Urogenital Disease | Products > Disease Areas > Inflammation or Immune System Disease | Products > Disease Areas > Prostate Cancer | Products > Signaling Pathways > GPCR/G Protein | Products > Signaling Pathways > Neuronal Signaling | Products > Research Areas > Inflammation/Immunology | Products > Signaling Pathways > Cannabinoid Receptor

Product Information

• Catalog No.: HY-14900
• CAS No.: 916591-01-0
• Molecular Formula: C19H21F2N3O
• Molecular Weight: 345.39
• Purity: 99.84%
• Storage: Powder -20°C, 3 years ; In solvent -80°C, 6 months , -20°C, 1 month
• Availability: In-stock

Source

Original product source